Facebook
X
LinkedIn
Forward
0643_SHVGR_Brain Health Series_Diagnosis of MCI and Early AD_Live
Description:
This one-hour lecture will provide an overview of the current state of practice at Sutter Health for the diagnosis and management of Mild Cognitive Impairment (MCI) and early Alzheimer’s dementia (AD). Participants will review the symptoms, pathophysiology, and clinical spectrum of MCI and early AD, along with best practices for cognitive screening in primary care using evidence-based tools. The session will also cover updates on biomarker testing, guidance on its appropriate use, and the latest disease-modifying treatments aimed at slowing disease progression and preserving brain health. Additionally, the lecture will highlight upcoming Sutter initiatives designed to enhance early detection and care coordination, including digital cognitive screening tools and streamlined referral pathways. By the end of this session, participants will be better equipped to recognize early signs of cognitive decline, implement effective screening strategies, and integrate new resources into their practice to improve outcomes for patients and families.
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:
SDOH
Lancet Commission. (2024). Dementia prevention, intervention, and care: 2024 report. The Lancet, 403(10381), 1432–1452. LINK TO ARTICLE HERE
U.S. Centers for Disease Control and Prevention (CDC). (2025). Social determinants of health and cognitive decline. Retrieved from LINK TO ARTICLE HERE
Implicit Bias
Alzheimer's Association. (2025). Dementia risk factors and health equity. LINK TO ARTICLE HERE
Target Audience
Nurse Practitioner (NP)
Nurse, Registered (RN)
Pharmacists (PharmD)
Physicians (MD or DO)
Physician Assistant (PA)
Social Workers
Psychologists
Other Healthcare Professionals
Learning Objectives
Upon completion of this activity, learners should be able to:
- Review the current state of Alzheimer's dementia (AD) and Mild Cognitive Impairment (MCI) practice at Sutter.
- Overview of the symptoms, pathophysiology, and clinical spectrum of MCI and early AD.
- Utilize optimal cognitive tools for primary care screening.
- Update and appropriately use biomarker testing for MCI
- Review disease modifying treatments to slow down progression and preserve brain health.
- Review upcoming Sutter initiatives for brain health.
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
This activity is supported in part by an unrestricted educational grant from Eli Lilly and Company. The support is for educational purposes only and does not include any influence over content, faculty selection, or educational methods.
Dr. Minal Bhanushali, faculty for this presentation, has disclosed financial relationships with ineligible companies within the past 24 months:
- Grant or Contract: Lilly Pharmaceuticals (Alzheimer’s dementia), effective 02/14/2025
- Consultant Fees: Lilly Pharmaceuticals (relationship ended 06/30/2025)
- Speaker Fees: Eisai Pharmaceuticals and Topline Research (relationship with Topline Research ended 08/31/2025)
The topics related to these relationships include Alzheimer’s dementia and perceptions and barriers around amyloid-targeted therapies for dementia management. These relevant financial relationships have been mitigated through peer review conducted by Dr. Shawn Kile, who has no financial relationships.
Armen Moughamian, MD, PhD, disclosed consulting relationships with Eisai and Eli Lilly, for which honoraria and consulting fees were received for serving on advisory boards. These relationships ended in 2023; therefore, no mitigation was necessary.
Dr. Gnanagurudasan Prakasam, a planning team member, disclosed consultant fees from Novo Nordisk (growth hormones), Medtronic (insulin pumps), Dexcom (glucose sensors), Mankind (inhaled insulin), Alexion (HPP), and K Kirin (XLH), as well as speaker fees from Lilly (diabetes), Sanofi (Type 1 diabetes prevention), and AbbVie (puberty). These relationships were deemed not relevant to this activity’s topic, and mitigation was not required.
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
Additional faculty involved the planning of this learning activity are as follows:
Jennifer Biltoft, Pharm.D., MHA, BCPS
Carolin Delker, NP
Max Ingersoll, FNP-BC, MSN
Jill Kacher Cobb, MD
Tam Nguyen, MD
Lori Petrini
Michelle Mah
Luanne Ridgley, LSW
Christopher Mack
Sharmi Mukherjee, PT
– Provider Designee/Verification: Fozia Ferozali, Ed.D
Accreditation
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.00 AMA PRA Category 1 Credits™ for physicians, 1.00 continuing professional development contact hours for nurses, 1.00 knowledge-based contact hours for pharmacists, and 1.00 ASWB learner credits for social workers. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Note to Other Disciplines: Non-Physician Participation Credit (AKA - AMA PRA Category 1 Credits HOURS™) Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Available Credit
- 1.00 ACPE
Pharmacy Credit - Accreditation Council of Pharmacy Education (ACPE)
Sutter Health designates this Live activity for a maximum of 1.00 of ACPE credit(s). Credits for pharmacists and technicians will be transmitted to CPE Monitor and will be available within 60 days post-activity pending submission of individual NABP e-PID and DOB (mm/dd only). Pharmacists should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
Physician Credit
Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Non-Physician Participation Credit
Sutter Health designates this Live activity for a maximum of 1.00 Non-Physician Participation Credit. Non-Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
- 1.00 ANCC
Nursing Credit - American Nurses Credentialing Center (ANCC)
Sutter Health designates this Live activity for a maximum of 1.00 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ASWB-ACE
Social Work Credit
As a Jointly Accredited Organization, Sutter Health is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 continuing education credits.
- 1.00 CA BRN
Nursing Credit - California Board of Registered Nursing (CA BRN)
This activity is approved for 1.00 contact hour(s) by Sutter Health, which is an approved provider by the California Board of Registered Nursing. (Provider Number 17182). Nurses should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 IPCE
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
- 1.00 PTBC
Physical Therapy Board of California
Sutter Health designates this Live activity for a maximum of 1.00 PTBC credit(s). Physical therapists should claim only the credit commensurate with the extent of their participation in the activity.